These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 26473839)
21. A semiparametric model for regression analysis of interval-censored failure time data. Finkelstein DM; Wolfe RA Biometrics; 1985 Dec; 41(4):933-45. PubMed ID: 3830259 [TBL] [Abstract][Full Text] [Related]
22. On improving human clinical trials to the level of animal ischemic stroke studies. Stein DG Metab Brain Dis; 2015 Apr; 30(2):469-71. PubMed ID: 25169818 [TBL] [Abstract][Full Text] [Related]
23. Translational clinical trials: an entropy-based approach to sample size. Piantadosi S Clin Trials; 2005; 2(2):182-92. PubMed ID: 16279140 [TBL] [Abstract][Full Text] [Related]
25. Stroke drug development: usually, but not always, animal models. Donnan GA; Davis SM Stroke; 2005 Oct; 36(10):2326. PubMed ID: 16141427 [No Abstract] [Full Text] [Related]
26. Designing prospective clinical pharmacogenomic (PG) trials: meeting report on drug development strategies to enhance therapeutic decision making. Trepicchio WL; Essayan D; Hall ST; Schechter G; Tezak Z; Wang SJ; Weinreich D; Simon R Pharmacogenomics J; 2006; 6(2):89-94. PubMed ID: 16402088 [No Abstract] [Full Text] [Related]
27. The pragmatic clinical trial in a learning health care system. Lewis RJ Clin Trials; 2016 Oct; 13(5):484-92. PubMed ID: 27365011 [TBL] [Abstract][Full Text] [Related]
28. Use of animal models has not contributed to development of acute stroke therapies: pro. Kaste M Stroke; 2005 Oct; 36(10):2323-4. PubMed ID: 16141431 [No Abstract] [Full Text] [Related]
29. Use of animal models has not contributed to development of acute stroke therapies: con. Fisher M; Tatlisumak T Stroke; 2005 Oct; 36(10):2324-5. PubMed ID: 16141429 [No Abstract] [Full Text] [Related]
30. Preclinical rare cancer research to inform clinical trial design. Barker HE; Scott CL Nat Rev Cancer; 2019 Sep; 19(9):481-482. PubMed ID: 31263218 [No Abstract] [Full Text] [Related]
31. The failure of torcetrapib: is there a case for independent preclinical and clinical testing? Doggrell SA Expert Opin Pharmacother; 2008 Apr; 9(6):875-8. PubMed ID: 18377331 [TBL] [Abstract][Full Text] [Related]
32. Complexity of the body calls for animal research. Smith CG Nature; 2004 Sep; 431(7005):125. PubMed ID: 15356604 [No Abstract] [Full Text] [Related]
33. Current practices in preclinical drug development: gaps in hemostasis testing to assess risk of thromboembolic injury. Schultze AE; Walker DB; Turk JR; Tarrant JM; Brooks MB; Pettit SD Toxicol Pathol; 2013; 41(3):445-53. PubMed ID: 22991386 [TBL] [Abstract][Full Text] [Related]
34. Clinical research in traditional medicine: priorities and methods. Cardini F; Wade C; Regalia AL; Gui S; Li W; Raschetti R; Kronenberg F Complement Ther Med; 2006 Dec; 14(4):282-7. PubMed ID: 17105698 [TBL] [Abstract][Full Text] [Related]
35. Bridging the gap between preclinical and clinical studies. Suckling K Curr Opin Investig Drugs; 2004 Sep; 5(9):928. PubMed ID: 15503645 [No Abstract] [Full Text] [Related]
36. Tyrosine kinase inhibitor (TKI)-induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome. Yang B; Papoian T J Appl Toxicol; 2012 Dec; 32(12):945-51. PubMed ID: 22961481 [TBL] [Abstract][Full Text] [Related]
38. Immunostimulatory antibodies: challenging the drug testing paradigm. Bhogal N; Combes R Toxicol In Vitro; 2007 Oct; 21(7):1227-32. PubMed ID: 17434714 [TBL] [Abstract][Full Text] [Related]
39. Trial by science. The basics of clinical research. Tsai A Diabetes Forecast; 2014 Dec; 67(12):48-52. PubMed ID: 25872366 [No Abstract] [Full Text] [Related]
40. [Control, drug preparation and dosage in the designing of experiments (author's transl)]. Chen X Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):335-8. PubMed ID: 6796231 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]